Tags: Health Topics | lung cancer | vaccine

10 Facts About Lung Cancer Vaccine CimaVax

By    |   Tuesday, 07 Jun 2016 06:53 PM

CimaVax was created in Cuba and has been used as a lung cancer vaccine for several years. The recently restored relationship between Cuba and the U.S. has allowed access to CimaVax.

According to a study by the American Society of Clinical Oncology, this lung cancer vaccine targets epidermal growth factor, a by-product of cancer cells, which appears to be abundantly present in malignant cancer cells. The lung cancer vaccine has an immunotherapy function and causes the immune system to produce and release antibodies to fight epidermal growth factor, stopping tumor growth.

The following 10 facts about the lung cancer vaccine, CimaVax, as reported by Medical Daily, the American Association for Cancer Research, and The Huffington Post show the promising future of a lung cancer vaccine in the United States.

Warning: Antibiotics Not a Solution, Use This First

1. CimaVax has the potential to stop tumor growth and the spreading of the malignancy. Researchers caution that a lung cancer vaccine such as CimaVax does not work by preventing lung cancer but instead initiates an immune response in a lung cancer patient to release antibodies to fight the cause of tumor growth — epidermal growth factor.

2. CimaVax is not a lung cancer cure but has the potential to slow down the progression of the disease by starving cancer.

3. CimaVax is affordable. In fact, Cuba spends just one dollar per shot.

4. A recent study by the American Society of Clinical Oncology reported the lung cancer vaccine increased survival rates for participants younger the ag 60.

Doctor: Antibiotics Do More Harm Than Good – Boost Your Immune System

5. Researchers predict the possibility that CimaVax may also treat and prevent other types of cancer.

6. When the lung cancer vaccine was used in study participants who were in remission from lung cancer, CimaVax worked to prevent future relapse of cancer.

7. Roswell Park Cancer Institute will hold clinical trials of the lung cancer vaccine and is awaiting approval by the FDA.

8. Lung cancer is the most deadly cancer in the U.S., says Dr. Kelvin Lee of the Roswell Park Cancer Institute.

9. The time estimated by the Roswell Park Cancer Institute to complete the research process is five years.

Fight Inflammation in Heart, Digestion, Skin, More ... Click to Learn More

10. CimaVax has been available to lung cancer patients in Cuba since 2011, free of charge.

© 2017 Newsmax. All rights reserved.

 
1Like our page
2Share
FastFeatures
CimaVax was created in Cuba and has been used as a lung cancer vaccine for several years. The recently restored relationship between Cuba and the U.S. has allowed access to CimaVax.
lung cancer, vaccine
400
2016-53-07
Tuesday, 07 Jun 2016 06:53 PM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved